<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04000000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q05823</UniProt_ID>
  <Seq_Length>741</Seq_Length>
  <Molecule_Weight>83533</Molecule_Weight>
  <KEGG_ID>hsa:6041</KEGG_ID>
  <Orthology_ID>K01165</Orthology_ID>
  <Function_Summary>Endoribonuclease that functions in the interferon (IFN) antiviral response. In INF treated and virus infected cells, RNASEL probably mediates its antiviral effects through a combination of direct cleavage of single-stranded viral RNAs, inhibition of protein synthesis through the degradation of rRNA, induction of apoptosis, and induction of other antiviral genes. RNASEL mediated apoptosis is the result of a JNK-dependent stress-response pathway leading to cytochrome c release from mitochondria and caspase-dependent apoptosis. Therefore, activation of RNASEL could lead to elimination of virus infected cells under some circumstances. Might play a central role in the regulation of mRNA. turnover.</Function_Summary>
  <Catalytic_Mechanism>Cleaves 3' of UpNp dimers, with preference for UU and UA sequences, to sets of discrete products ranging from between 4 and 22 nucleotides in length.</Catalytic_Mechanism>
  <Pfam_ID>PF00023:Ank@@PF00069:Pkinase@@PF06479:Ribonuc_2-5A</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Ribonuclease 4</Alias>
      <Alias>2-5A-dependent RNase</Alias>
      <Alias>RNase L</Alias>
      <Alias>Ribonuclease L</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of ester linkages within ribonucleic acids by creating internal breaks to yield 5'-phosphomonoesters.</Detail>
      <Keyword>Endoribonuclease activity, producing 5'-phosphomonoesters</Keyword>
      <Ontology_ID>GO:0016891</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.</Detail>
      <Keyword>Protein kinase activity</Keyword>
      <Ontology_ID>GO:0004672</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of ester linkages within nucleic acids.</Detail>
      <Keyword>Nuclease activity</Keyword>
      <Ontology_ID>GO:0004518</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks.</Detail>
      <Keyword>Endonuclease activity</Keyword>
      <Ontology_ID>GO:0004519</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>541</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>462</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>592</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>406</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>289</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication.</Detail>
      <Keyword>Negative regulation of viral genome replication</Keyword>
      <Ontology_ID>GO:0045071</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.</Detail>
      <Keyword>Response to virus</Keyword>
      <Ontology_ID>GO:0009615</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Reactions triggered in response to the presence of a virus that act to protect the cell or organism.</Detail>
      <Keyword>Defense response to virus</Keyword>
      <Ontology_ID>GO:0051607</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.</Detail>
      <Keyword>Type I interferon-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0060337</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.</Detail>
      <Keyword>MRNA processing</Keyword>
      <Ontology_ID>GO:0006397</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transcription from the RNA polymerase II promoter.</Detail>
      <Keyword>Positive regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0045944</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>684</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MESRDHNNPQEGPTSSSGRRAAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDLVMTARRNYDHSLVKVLLSHGAKEDFHPPAEDWKPQSSHWGAALKDLHRIYRPMIGKLKFFIDEKYKIADTSEGGIYLGFYEKQEVAVKTFCEGSPRAQREVSCLQSSRENSHLVTFYGSESHRGHLFVCVTLCEQTLEACLDVHRGEDVENEEDEFARNVLSSIFKAVQELHLSCGYTHQDLQPQNILIDSKKAAHLADFDKSIKWAGDPQEVKRDLEDLGRLVLYVVKKGSISFEDLKAQSNEEVVQLSPDEETKDLIHRLFHPGEHVRDCLSDLLGHPFFWTWESRYRTLRNVGNESDIKTRKSESEILRLLQPGPSEHSKSFDKWTTKINECVMKKMNKFYEKRGNFYQNTVGDLLKFIRNLGEHIDEEKHKKMKLKIGDPSLYFQKTFPDLVIYVYTKLQNTEYRKHFPQTHSPNKPQCDGAGGASGLASPGC</Protein_Seq>
    <DNA_Seq>AGTGACGCAGCAGGAGGAAACTGCTCGGGCTGCAAGCAGTCTTCCAGGCTTTGCGGCTGCCAAAGGAATAATTGAGACGTCTGAGTTGAGCAGGTGGAATGTCAGAAGACTGAGAACATTGTTCCTTCTTCATACTGCTGCTCTGTTGCCAGAGAATCCCAATTTACACTCAAAGCTTCTTTGATTAAGTGCTAGGAGATAAATTTGCATTTTCTCAAGGAAAAGGCTAAAAGTGGTAGCAGGTGGCATTTACCGTCATGGAGAGCAGGGATCATAACAACCCCCAGGAGGGACCCACGTCCTCCAGCGGTAGAAGGGCTGCAGTGGAAGACAATCACTTGCTGATTAAAGCTGTTCAAAACGAAGATGTTGACCTGGTCCAGCAATTGCTGGAAGGTGGAGCCAATGTTAATTTCCAGGAAGAGGAAGGGGGCTGGACACCTCTGCATAACGCAGTACAAATGAGCAGGGAGGACATTGTGGAACTTCTGCTTCGTCATGGTGCTGACCCTGTTCTGAGGAAGAAGAATGGGGCCACGCCTTTTATCCTCGCAGCGATTGCGGGGAGCGTGAAGCTGCTGAAACTTTTCCTTTCTAAAGGAGCAGATGTCAATGAGTGTGATTTTTATGGCTTCACAGCCTTCATGGAAGCCGCTGTGTATGGTAAGGTCAAAGCCCTAAAATTCCTTTATAAGAGAGGAGCAAATGTGAATTTGAGGCGAAAGACAAAGGAGGATCAAGAGCGGCTGAGGAAAGGAGGGGCCACAGCTCTCATGGACGCTGCTGAAAAAGGACACGTAGAGGTCTTGAAGATTCTCCTTGATGAGATGGGGGCAGATGTAAACGCCTGTGACAATATGGGCAGAAATGCCTTGATCCATGCTCTCCTGAGCTCTGACGATAGTGATGTGGAGGCTATTACGCATCTGCTGCTGGACCATGGGGCTGATGTCAATGTGAGGGGAGAAAGAGGGAAGACTCCCCTGATCCTGGCAGTGGAGAAGAAGCACTTGGGTTTGGTGCAGAGGCTTCTGGAGCAAGAGCACATAGAGATTAATGACACAGACAGTGATGGCAAAACAGCACTGCTGCTTGCTGTTGAACTCAAACTGAAGAAAATCGCCGAGTTGCTGTGCAAACGTGGAGCCAGTACAGATTGTGGGGATCTTGTTATGACAGCGAGGCGGAATTATGACCATTCCCTTGTGAAGGTTCTTCTCTCTCATGGAGCCAAAGAAGATTTTCACCCTCCTGCTGAAGACTGGAAGCCTCAGAGCTCACACTGGGGGGCAGCCCTGAAGGATCTCCACAGAATATACCGCCCTATGATTGGCAAACTCAAGTTCTTTATTGATGAAAAATACAAAATTGCTGATACTTCAGAAGGAGGCATCTACCTGGGGTTCTATGAGAAGCAAGAAGTAGCTGTGAAGACGTTCTGTGAGGGCAGCCCACGTGCACAGCGGGAAGTCTCTTGTCTGCAAAGCAGCCGAGAGAACAGTCACTTGGTGACATTCTATGGGAGTGAGAGCCACAGGGGCCACTTGTTTGTGTGTGTCACCCTCTGTGAGCAGACTCTGGAAGCGTGTTTGGATGTGCACAGAGGGGAAGATGTGGAAAATGAGGAAGATGAATTTGCCCGAAATGTCCTGTCATCTATATTTAAGGCTGTTCAAGAACTACACTTGTCCTGTGGATACACCCACCAGGATCTGCAACCACAAAACATCTTAATAGATTCTAAGAAAGCTGCTCACCTGGCAGATTTTGATAAGAGCATCAAGTGGGCTGGAGATCCACAGGAAGTCAAGAGAGATCTAGAGGACCTTGGACGGCTGGTCCTCTATGTGGTAAAGAAGGGAAGCATCTCATTTGAGGATCTGAAAGCTCAAAGTAATGAAGAGGTGGTTCAACTTTCTCCAGATGAGGAAACTAAGGACCTCATTCATCGTCTCTTCCATCCTGGGGAACATGTGAGGGACTGTCTGAGTGACCTGCTGGGTCATCCCTTCTTTTGGACTTGGGAGAGCCGCTATAGGACGCTTCGGAATGTGGGAAATGAATCCGACATCAAAACACGAAAATCTGAAAGTGAGATCCTCAGACTACTGCAACCTGGGCCTTCTGAACATTCCAAAAGTTTTGACAAGTGGACGACTAAGATTAATGAATGTGTTATGAAAAAAATGAATAAGTTTTATGAAAAAAGAGGCAATTTCTACCAGAACACTGTGGGTGATCTGCTAAAGTTCATCCGGAATTTGGGAGAACACATTGATGAAGAAAAGCATAAAAAGATGAAATTAAAAATTGGAGACCCTTCCCTGTATTTTCAGAAGACATTTCCAGATCTGGTGATCTATGTCTACACAAAACTACAGAACACAGAATATAGAAAGCATTTCCCCCAAACCCACAGTCCAAACAAGCCTCAGTGTGATGGAGCTGGTGGGGCCAGTGGGTTGGCCAGCCCTGGGTGCTGATGGACTGATTTGCTGGAGTTCAGGGAACTACTTATTAGCTGTAGAGTCCTTGGCAAATCACAACATTCTGGGCCTTTTAACTCACCAGGTTGCTTGTGAGGGATGAGTTGCATAGCTGATATGTCAGTCCCTGGCATCGTGTATTCCATATGTCTATAACAAAAGCAATATATACCCAGACTACACTAGTCCATAAGCTTTACCCACTAACTGGGAGGACATTCTGCTAAGATTCCTTTTGTCAATTGCACCAAAAGAATGAGTGCCTTGACCCCTAATGCTGCATATGTTACAATTCTCTCACTTAATTTTCCCAATGATCTTGCAAAACAGGGATTATCATCCCCATTTAAGAACTGAGGAACCTGAGACTCAGAGAGTGTGAGCTACTGGCCCAAGATTATTCAATTTATACCTAGCACTTTATAAATTTATGTGGTGTTATTGGTACCTCTCATTTGGGCACCTTAAAACTTAACTATCCTTCCAGGGCTCTTCCAGATGAGGCCCAAAACATATATAGGGGTTCCAGGAATCTCATTCATTCATTCAGTATTTATTGAGCATCTAGTATAAGTCTGGGCACTGGATGCATGAATTCCACTCCTTCCAGAACCAACTGCATTGGTTTTCCATGACCTTAAGGCAGTAGTTCTCAACTGGGGGGCAATTTTGCACTGAAGAGAGCATTTGGCAGAGTCTGAAGAAGTTTTTGGTGTCACAGCTTTGTGGGGAGCATGCTATGGCATTTAGTGGGTAAAGACCAGGGATGCTGCCAAACCTGCCTTGCACAGGACAGCCCCTGCAACAAAGAATTATCCAGACAAAAATATCAATGGTGCTGAGGTTGAGAAAACCTGACTTAAGGGGCTGGGATGCTTTTGAACTAGCTTAAGGCCCAGGACTGTGGAGTGTGTGGACCACCCCACAGAGGAGGGACTCAGATTTATTTACTCTTGCTGGATCTGTAGTGATGGAGTTCCTTCTGGTGTCAGCCCCACAGGAGGCTCCCAGGCCTCCCTCACTTCCCATACCCAGTCTAGGAGCTCCTTCTGGCTCCCAAGCACCCAGAGCTTTCCTCCGCCTTTTAGTTTTGGTTCCTCCACTGGAATGTAGGCTCCTCACGGGCGATGGCTGTCTTTTCTTGACTTTGTATCTTCACTGCCAAGCAAAAAGTCTGCCAAGTGGGAATGTTTAATAAATATTCATTGAATAATGAATGAACCATCTTCGTACATGAATAATAATACTGTCTTACGTTTTTCTGGTGCTTTATAATGTATACATTACATCTGAGTATTTTATTTTATTTAATTTTCAAAACAATCCTTTAAGGTCAACATTGTTATCCTTATTTTGCTGATGAGGAAACTAAGGTTAGAAACATTTTGATTTCCTCTAGGACGTATAGCTAGGAAGTGTTACTATCTTGATTTGAACAAATTTTCTGGTGCTAAGTCTGATGTTCTTTCCATGAATCATTGTGGTGGTTGAGATGGAGCTTTGTAATGGGAATAAAACAGTACCTTAGGTTCTTTCTGAAAAGGAGGTATCTAGCAATGGATAAATAGATACCACTGAATGAAATTAAATGTTGATTAGGAACAAATTTAAGGCTTAAAAAATACTTTATGAGCAGCAAGATTGCTTTAACTTTTAAAATGAAGCTTTGGTTCTCTGATTTGTAATGAGCACCTGGATATGTCAATTAAAATGCCCATTTGTGAAGCTTACTCAATAAAACTTTAAATTGTCTTAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Colon</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Small intestine</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Prostate</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Uterus</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Thymus</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Peripheral blood leukocytes</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Mitochondrion</CellLocal>
      <Ontology_ID>GO:0005739</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>RNASEL</Gene_Name>
    <Gene_Alias>RNS4</Gene_Alias>
    <Gene_ID>6041</Gene_ID>
    <Genbank_ACCN>NM_021133</Genbank_ACCN>
    <Protein_ACCN>NP_066956</Protein_ACCN>
    <HGNC_ID>10050</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/6041</Gene_URL>
    <UCSC_ID>uc009wxz.2</UCSC_ID>
    <EMBL_ID>ENSG00000135828</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Lynch Syndrome</Disease_Name>
      <Disease_Detail>Lynch Syndrome</Disease_Detail>
      <Disease_DB>LYN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lynch_syndrome?search=RNASEL#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer?search=RNASEL#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Fatigue Syndrome</Disease_Name>
      <Disease_Detail>Chronic Fatigue Syndrome</Disease_Detail>
      <Disease_DB>CHR066</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_fatigue_syndrome?search=RNASEL#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parainfluenza Virus Type 3</Disease_Name>
      <Disease_Detail>Parainfluenza Virus Type 3</Disease_Detail>
      <Disease_DB>PRN029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parainfluenza_virus_type_3?search=RNASEL#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer 1</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS116</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer_1?search=RNASEL#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of ribonuclease</PDB_Title>
      <PDB_ID>1WDY</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WDY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L</PubMed_Title>
      <Author>Tanaka, N., et al.</Author>
      <Journal>Embo J.(2004)23:3929-3938</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15385955?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05164</Pathway_ID>
      <Pathway_Title>Influenza A</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.ia.b.b.bj.html</SCOP_URL>
    <CATH_Class>Class 1: Mainly Alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1wdy</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.1.26.-</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/26/-.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>